SlideShare a Scribd company logo
1 of 50
UNIVERSAL MEDICAL COLLEGE
PRESENTESSION FOR
PHARMACY PRACTICE ATTACHMENT
BY SAMSON G/HIWOT
ID.NO = PHDE/1604/12
FEB 2020
Objectives of this attachment
 To enable students identify those drugs which are commonly available in
community pharmacy.
 To enable students identify common emergency medicines available in
community pharmacy.
 To enable students develop capacity in provision of pharmaceutical care in
community pharmacy.
 To enable students identify those medical supplies which are available in
community pharmacy.
INTRODUCTION
 Name of the organization is Simret Drug store
 Simret Drug store Found in Debrebrehan Town North showa zone Infront
of Debrebrehan Health center 04 kebele.
 This organizations are contain two manpower(2 pharmacy professional)
 One security
 Average number of customers came in pharmacy per day = 55
 Layout of the pharmacy
 Human resource
◦ Pharmacy technicians, = 2
◦ Other support staff ( guard).
◦ Pharmacist(s) and other staff on duty must wear a
name tag or badge indicating his/her name and
designation.
 Appearance of pharmacy premises
 Design and layout:
◦ Permit flow of work, effective communication and
supervision and ensure effective cleaning
◦ Minimize the cross-contamination and anything else
◦ All parts of the premises was maintained in an orderly and
tidy condition.
◦ The external appearance of the pharmacy depict a
professional image.
◦ Entrances, dispensing counters and doorways are
accessible to disabled persons.
 Security in pharmacy premises
 Careful consideration the overall security of the pharmacy.
◦ Access to a pharmacy when it is locked
◦ Control of access to medicine
 Safety of pharmacy premises
◦ Working conditions
◦ Fire extinguisher
◦ Electrical equipment → safe and maintained regularly.
 Condition of pharmacy premises
 The walls, floors, windows, ceiling, and all other parts of the premises →cleaned and good
ordered.
 shelves and walls →finished in a smooth, washable and impermeable material.
 Site of premises
◦ Fared from areas or premises that can cause contamination to the products and affect health in
general (e.g. public toilets, waste dump site)
 Construction of pharmacy premises
 Preventing from:
◦ floods
◦ entry of insects, animals or birds
 Easily cleaned and disinfected
 Allows adequate lighting and air movement
 Ceiling :
◦ Should minimizes effects of high temperatures
◦ Adequate height
 Environment in pharmacy premises
 Products stored according to recommended conditions
 Levels of heat, light, noise, ventilation, etc., must exert no adverse effects on
pharmaceutical stock as well as personnel.
 Suitable and effective means of heating or cooling, lighting and ventilation.
 Hygiene in pharmacy premises
 Regular program for cleaning premises
 Area for washing equipment and other utensils (hot and cold tap water).
 Toilet facilities must be kept clean and in good order.
 Hand-washing facilities
 Premises Dispensary
 The size of the dispensary:
 allow a safe and efficient flow of work and
 effective communication and supervision
 arrangement of available space and
 space available elsewhere for storage of stock.
 Waiting area
 Comfortable seating must be provided.
 Appropriate health-related literature must be provided
 This pharmacy fulfilled Ethiopian guideline like : 25m²
minimum for dispensary and waiting area with shortest side not
less than 4 m.
 Suitability of dispensary
 The dispensary, its fittings and equipment was adequate and
suitable for the purpose of dispensing.
 The temperature in the dispensing maintained below 25°C.
 Counseling area
 The area(s)
◦ Be easily accessible
◦ Ensured reasonable privacy to the patient at all times and eliminate
background noise as far as possible.
◦ Have sufficient space →appropriate counseling and demonstration
of the correct and safe use of medicines.
 Storage areas in pharmacy premises
◦ independent and secured
◦ Large enough → orderly arrangement and proper stock rotation
◦ Sufficient shelving
 Fulfilled Ethiopian guideline like : 16 m² minimum for storage with
shortest side not less than 3 m.
 Other issues
 Waste disposal → SOPs
◦ Suitable and adequate means in written form
 Dispensing equipment and materials
◦ Adequate, suitable dispensing equipment. (not all)
◦ Maintained clean,
 Availability of Refrigerator
Services rendered in community
pharmacy
 The major work of community pharmacists involves supplying
medicines to the public:
1. Dispensing prescriptions
2. Patient information and advice
3. Compounding
4. Record keeping
5. Public health Services
6. Medication therapy management (MTM) and standards
1. Dispensing prescriptions
1. Dispensing prescriptions
 The supply of medicines according to:
 Good dispensing practices,
 Good compounding practices
 Maintaining records and
 SOPs followed
 Good dispensing practices
 The dispensing process is divided into three phases, namely:
 Phase 1: Interpretation and evaluation of the prescription.
 Phase 2: Labeling and preparation of the prescribed medicine.
 Phase 3: Hand to the patient and counseling.
 Phase 1: Interpretation and evaluation of the prescription
 Receipt of the prescription and confirmation of the integrity of the
communication.
◦ identifying the patient, the prescriber,
◦ legality/authenticity of the prescription,
◦ medication history
 Phase 2: Labeling and preparation of the prescribed
medicine
 Labeling of item(s)
 Selecting or preparing the medicine
◦ patient-ready packs/pre-packed medicines
◦ extemporaneous preparations
◦ pharmaceutical containers
 Checking
 Record keeping regarding the supply of medicine
 Phase 3: Hand to the patient and Counseling
 Supply to the patient
 Counseling to be done by a pharmacist
 Patient information leaflet
 Monitoring patient outcomes
 assess the patient for signs of compliance, effectiveness and safety
of the therapy
 identify areas for interventions, intervene, revise the patient record
and record the action taken
 Read: Ethiopian Good Dispensing Manual
2. Patient information and advice
 Patient information and advice is of vital importance in the correct use of
medicines
 It must respect patient autonomy, improve health and enhance the outcome of
medical treatment by:
◦ empowering consumers to make informed decisions about their treatments and take
responsibility for their own health care;
◦ improving communication between patients and health care providers; and
◦ aiding and encouraging effective use of medicines.
 Supplementary written information must be used (as appropriate).
 The pharmacist must assess each patient's ability to understand the information
imparted.
 Confidentiality of the patient must be respected.
 The provision of advice must take place in a suitable environment.
 Steps for counseling a patient on a new prescription
o Introduce yourself and identify the patient.
o Ask patient to talk with you about the medication.
o Assess the patient's understanding of his/her disease and expected
outcomes of therapy.
o Assess patient’s knowledge about the newly prescribed drug and the
reason it was prescribed.
o Assess patient’s knowledge on how to take the medication as well as its
potential adverse effects.
3. GOOD COMPOUNDING PRACTICE
(GCP)
 Definition
 Compounding is the preparation of a customized prescription medication to meet the
individual patient needs in response to a licensed practitioner's prescription.
 Why Compound?
 Problem Solving…
 Unavailable Strength/Dosage
 Unavailable Medications (limited use, short shelf life, etc.)
 Sensitivity to Dyes, Fillers, Preservatives
 Basic components of GCP
 Personnel
 Facilities
 Equipment
 Ingredients
 The compounding process
 Packaging and labeling
 Stability and beyond-use date
 Records and reports
4. Record keeping
 Must be both accurate and up-to-date.
◦ Compounding record
◦ Prescription Registration
◦ Patient medication records
◦ Stock records
◦ Health-screening related
5. public health service
 Public health is part of the community pharmacist’s roles:
◦ Disease prevention
◦ Health promotion
 Promoting healthy lifestyles consists of two separate areas:
◦ prescription-linked intervention
◦ involvement in public health campaigns.
 Prescription-linked intervention involves offering opportunistic advice on public
health topics to patients that present a prescription.
 Promotion of healthy lifestyles will include offering advice in the following areas:
◦ STDs and HIV/AIDS
◦ Infectious diseases such as malaria, URTIs and diarrheal diseases
◦ FP and child care
◦ Antimicrobial resistance
◦ CVDs, Cancer, Diabetes
 Health issues: stopping smoking, alcohol intake, nutrition advice and increased physical
activity, etc.
 Other professional services
 Retailing
 Remuneration/methods of payment:
◦ Markups on individual items and income derived solely from the sale of medicines,
◦ Fixed dispensing fees
 Managerial skills
 Financial strategy and planning
 Marketing
 Problem solving
 Emergency hormonal contraceptives (‘morning-after-pill’).
 Emergency contraception (EC) refers to contraceptive methods that may be used in the first
few days after unprotected sexual intercourse, to prevent unwanted pregnancy.
 It potentially reduces unintended pregnancy and (unsafe) abortion rates.
 Health screening:
◦ Body weight and height;
◦ Blood pressure;
◦ Blood glucose;
◦ Pregnancy;
◦ Cholesterol;
◦ Peak flow test;
◦ HIV
 Requirements: facilities and training
 Appropriate public health education and counseling
 First aid provision
 Emergency treatment of wounds; bone fractures; burns; bleeding;
foreign objects in nose, ear, eye and respiratory system; severe
diarrhea; high fever; poisoning and snake bite; etc.
 Adverse drug reaction reporting
o Report suspected adverse drug reactions (ADRs) to the regulatory body
(e.g. Food, Medicines and Healthcare Administration and Control
Authority, FMHACA)
o For new drugs that have received market authorization in the last 2
years) for which any suspected ADRs should be reported
o All other drugs, for which only serious suspected ADRs should be
reported.
 Nutrition advice (diabetes, hypertension, pregnancy, etc.)
 Site for training of pharmacy interns
 Drug information services
◦ General public
◦ Healthcare providers
 Immunization services
◦ travel,
◦ childhood,
◦ tetanus, etc.
 Smoking cessation clinics
 Pharmacies are recognized as being well placed to offer a smoking-cessation service as
they are readily accessed by the public and have a resident healthcare professional.
 Pharmacists are involved routinely in brief interventions as part of the essential service
promoting healthy lifestyles.
 Initial and follow up consultations
 Nicotine replacement therapy (NRT)
 NRT delivers nicotine in a clean form and helps smokers to overcome withdrawal symptoms such as
irritability and craving while avoiding the many harmful chemicals in tobacco and the carbon monoxide
that cause serious damage.
 There are many different forms of NRT available including patches, gum, sublingual tablets, lozenges,
inhalators and nasal spray.
6. Medication therapy management (MTM)
 Requirements for MTM Programs are “designed” to “optimize therapeutic outcomes through
improved medication use” and “reduce the risk of adverse events, including adverse drug
reactions.”
 Objectives are to increase patient adherence, prevent drug complications, and enhance patient
understanding of their medication therapy.
 A MTM program established for targeted beneficiaries such as those who
o have multiple chronic disease states
o are taking multiple drugs,
 Core elements for MTM services
 Medication therapy review,
 Personal medication record,
 Medication-related action plan,
 Intervention and/or referral, and
 Documentation and follow-up
OBSERVA TION A ND DISCUSSION
 Strength
 supplying medicines to the public:
1. Dispensing prescriptions
2. Patient information and advice
3. Record keeping
4. Medication therapy management (MTM)and standards
◦ Minimize the cross-contamination and anything else
◦ All parts of the premises was maintained in an orderly and tidy
condition.
◦ The external appearance of the pharmacy depict a professional
image.
 Entrances, dispensing counters and doorways are accessible
to disabled persons.
 Safety of pharmacy premises
◦ Working conditions
◦ Fire extinguisher
◦ Electrical equipment → safe and maintained regularly.
 The walls, floors, windows, ceiling, and all other parts of the premises
→cleaned and good ordered.
 shelves and walls →finished in a smooth, washable and impermeable
material.
 Construction of pharmacy premises
 Preventing from:
◦ floods
◦ entry of insects, animals or birds
 Easily cleaned and disinfected
 Allows adequate lighting and air movement
 Ceiling :
◦ Should minimizes effects of high temperatures
◦ Adequate height
 Environment in pharmacy premises
 Products stored according to recommended conditions
 Levels of heat, light, noise, ventilation, etc., must exert no
adverse effects on pharmaceutical stock as well as personnel.
 Suitable and effective means of heating or cooling, lighting and
ventilation.
 Hygiene in pharmacy premises
 Regular program for cleaning premises
 Area for washing equipment and other utensils (hot and cold
tap water).
 Toilet facilities must be kept clean and in good order.
 Hand-washing facilities
 Waiting area
 Comfortable seating must be provided.
 Suitability of dispensary
 The dispensary, its fittings and equipment was adequate and
suitable for the purpose of dispensing.
 The temperature in the dispensing maintained below 25°C.
 Counseling area
 The area(s)
◦ Be easily accessible
◦ Ensured reasonable privacy to the patient at all times and eliminate
background noise as far as possible.
 Have sufficient space
 Storage areas in pharmacy premises
◦ independent and secured
◦ Large enough → orderly arrangement and proper stock
rotation
◦ Sufficient shelving
 Waste disposal → SOPs
◦ Suitable and adequate means in written form
 Have Good stock clasification methode
 Dispensing equipment and materials
◦ Adequate, suitable dispensing equipment. (not all)
◦ Maintained clean,
Weakness
 Prescribed Prescription drugs with out physician
 No ADR registration form
 No Report format (IFRR/RRF)
 NO BIN CARd
 There is no Compounding room
 There is no
 secretarial
 managerial activities office with appropriate furniture and equipments
 stock recording and other relevant documents are no applicable
 No participated in Health education
 Common ones include:
◦ Tablets and capsules counting equipments/apparatuses have not .
 Have not Current editions available like :
◦ Martindale;
◦ Drug interactions reference source;
◦ a comprehensive textbook on pharmacology/pharmacotherapy;
◦ Standard Treatment Guidelines and Essential Drug List for the
appropriate level of care.
◦ A pediatric dosing reference guide (where applicable);
◦ A medical dictionary;
 Dispensing equipment and materials are
o Not Adequate and suitable dispensing equipment.
 Have no Staff room like:-
◦ Cloak room
◦ Tea room
 There is no cashier, accountant, cleaner in the layout of the
pharmacy
Contribution/lesson learned
during staying
 From this lesson I learned about Services given to the
Community Pharmacy like:
1. Dispensing prescriptions
2. Patient information and advice
3. Record keeping
4. Medication therapy management (MTM) and standards
 I contributed that different areas specialy occurring of the weakness
 I make a significant contribution to public health through their day-to-day activities. These
include :-
o provision of information and advice,
o facilitating self-care,
o care and support of drug users,
o visits to the homes of housebound people
o advice on smoking cessation and
o emergency hormonal contraception.
o I dispensed prescription and non prescription drugs with stepwise
o I given adequated patient information and advices
o I prepared adequated record keeping materials
o I given health education about infection prevention for the public
o I recommended to fullfilled the occurrence of weakness like,compounding
room,separate tea room,current editions available,dispensing
equipement,medicine counter and record keeping log books.
o Finally ,I contributed and recommended that all pharmacy professionals
responsible for appropriate use of medication, and to achieve optimum therapeutic
outcomes like:-
 Cure of a disease
 Elimination or reduction of a patient’s symptoms
 Arresting or slowing of a disease process
 Preventing a disease
.During attachment peroid I attracted by availability of
different drugs
 patient privacy
Patient satisfaction
SUMMA RY A ND R ECOMMENDA TIONS
 Based on occurance of the weakness the following recommendations
were made for future actions:
 The pharmacy professionals should work hard to fulfilled atleast
minimum standards.
 They should fulfilled compounding room in the next months
 They should fulfilled secretarial ,managerial activities office with
appropriate furniture and equipments
 They should applicable stock recording and other relevant documents
 Tablets and capsules counting equipments should be applicable
 Current editions should be available like :-
◦ Martindale;
◦ Drug interactions reference source;
◦ a comprehensive textbook on pharmacology/pharmacotherapy;
◦ Standard Treatment Guidelines and Essential Drug List for the appropriate
level of care.
◦ A pediatric dosing reference guide (where applicable);
◦ A medical dictionary;
 They should be fullfilled Adequate and suitable dispensing equipment.
 They should be fulfilled cashier, accountant, cleaner in the layout of the
pharmacy
 They should be avail Staff room like:-
◦ Cloak room
◦ Tea room
The community pharmacy professionals
should be
 avoid non phycians prescreptions
 Avail bin card,
 Avail ADR registration form
 Avail Report format (IFRR/RRF)
6/13/2023 41
3. References
 (http://fmhaca.gov.et/Documents/Good Dispensing manual new 2.pdf)
 Hassan, W. E. Jr. Hospital Pharmacy, 5th ed. Lea and Febiger,
Philadelphia, 1986.
 Remington’s Pharmaceutical Science, 21st ed., Lippincott Williams &
Wilkins, Pennsylvania, 2006.
 Peterson A. M. Managing Pharmacy Practice: Principles, Strategies,
and Systems, CRC, Boca Raton, 2004.
 FMHACA documents listed in the text.
5 .U N SELIN G TIP M ON OGR A PH
PR EPA R ATION
I. Gastro-intestinal Tract Drugs(G.I.T.)
1. Generic name -Metoclopramide:
2. Brand name :RegurgeR
3. Dosage form available : tablets and solution) and as a parenteral preparation for intravenous or intramuscular
use.
4. Strength available :5mg,10mg
5. MOA:Block dopamine receptors when given in higher doses)also block serotonine receptors in CTZ of the
CNS;enhances the response to Ach ofb tissue in upper RT causing enhanced motility and accelerated gastric
emptying with out stimulating gastric,biliary or pancreatic secretions,increase LEST
6. Indication: In non-ulcer dyspepsia, for speeding transit time of barium during intestinal induced nausea and
vomiting, in oesophageal reflux.
7. Dose and admn : Oral,I.M. or I.V., 10 mg (5 mg in Patients15-19 years) 3 times/day.Child up To 1year1mg twice
/ day;1-3 years1 mg 2-3 times/day; 5-9 years 2.5 mg 3 times /day; 9-14 years 5 mg 3 times / day. Before
radiological examination,a single I.M dose of 10-20 mg (10 mg in young adults); childunder 3 years 1 mg, 5-9
years 2.5 mg, 9-14 years 5 mg by continuous I.V. infusion, before starting chemotherapy, 2-4/kg mg over 15-30
minutes, hen 3-5 mg/kg over 8-12 hours (maximum 10 mg/kg/day).
8.Common S/E: May induce extrapyramidal manifestations (facial and skeletal muscle spasm
and oculogyric crisis) in young patients.
9.C/I: GIT hemorrhage, obstruction, perforation or immediately after surgery
10.Pregnancy category:C
11.Patient instructions: Patient instructions:
Take each dose 30 minutes before meals and at bedtime.
Use caution when performing other tasks requiring mental alertness.
Report any involuntary movements especially in children and elderly.
12.Precautions: Renal and hepatic impairment; in elderly and under 20 years,pregnancy and
lactation, patients with hypertension, parkinsonism,history of depression and after gut
anastomosis in patients with diabetic gastroparesis,insulin dosage or timing might require
adjustment.
1. Generic name - Aluminum Hydroxide Combinations
2. Brand name : ALUSIL,NORMACID MPS GELR
3. Dosage form available :Chewable tablets and Suspensions
4. Strength available :370mg,475mg suspension
5. MOA:by neutralizing Acid-capacity
6. Indication: For use in dyspepsia and in hyperphosphataemia.
7. Dose and admn: Suspension, 5-10 ml (tablets,1-2 tablets chewed)4 times /day between and
bedtime.Child 6-12 year, up to 5 ml times /day.
8. Common S/E: Constipation, intestinal obstruction (large doses),hypercalciuria and risk of
osteomalacia.
9. C/I: Hypophosphataemia, porphyria, undiagnosed gastrointestinal or rectal bleeding.
10. Pregnancy category:C excretion in breast milk unknown
11. Patient instructions:
 Do not take for longer than 2 weeks.
 Taking too much can cause stomach to secrete excess stomach acid.
 Reduce acidity for about 30 minutes when taken on an empty stomach and for about 3
hours when taken 1 hour after meals.
12. Precautions: impaired renal function and renal dialysis, constipation,dehydration, fluid
restriction
I. Antispasmodics
1. Generic name : Atropine sulphate
2. Brand name :AtrezaR
,AtropineR
3. Dosage form available : I.V injection
4. Strength available :1mg/ml
5. MOA: Atropine antagonizes the effect of acetylcholine by competing for the muscarinic
receptors peripherally and in the CNS; therefore the effects of atropine are opposite to the
acetylcholine effects.
6. Indication: Adjust to the treatment of gastric and duodenal ulcers to facilitate radiological
examination of the gut,treatment of irritable bowel syndrome,with opiate analgesics in biliary and
ureteric colics, in parkinsonism, in the treatment of some arrhythmias (sinus bradycardia and heart
block), in the treatment of irreversible anti-cholinesterase poisoning, mushroom poisoning as a
pre-medicate in anesthesia with neostigmine to control its side effects in reversal of competitive
neuro-muscular blockers and in ophthalmology ( refraction , iridocyclitis and convergent squint )
7. Dose and admn: Pre-medicated, I.V injection, 300-600 micrograms immediately before
induction and in incremental doses of 100 micrograms for the treatment of bradycardia.With
neostigmine, 0.6-1.2 mg
8. Common S/E:
- lower doses produce sedation
- higher doses produce excitation, agitation and hallucination
- Dry mouth, constipation, mydriasis and cycloplegia,increased intra-ocular pressure, flushing,
rashes, dry skin, palpitations and arrhythmia and difficulty in micturition
9. C/I: Glaucoma, prostatic enlargement, pyloric stenosis,ulcerative colitis, hepatic and renal
disease, tachycardia, myocardial ischemia, myasthenia gravis, unstable cardiovascular status, in
acute hemorrhage.
10. Pregnancy category:C
11. Patient instructions:
 Adequate oral fiber intake
 Not to drive, dilated pupils (mydriasis).
12. Precautions: Extremes of age, infants below 3 month, fever, thyrotoxicosis,cardiac
insufficiency, hypertension, Down syndrome
I. Selective Angiotensin II inhibitor(C.V.S.)
1. Generic name: Nifedipine
2. Brand name :Nife – SSP20,Afeditab CR
3. Dosage form available :20mg,40mg tablets
4. Strength available :20mg,40mg tablets
5. MOA: inhibition of calcium influx in to arterial smooth muscle cells,
6. Indication: Angina pectoris (classic and vasospastic), hypertension and Raynaud disease.
7. Dose and admn: Angina, initially 10mg 3 times /day, increase to 20 mg 3 times / day if
necessary. In elderly initially 5mg 3 times /day (for immediate effect bite capsule and retain liquid
in mouth). Raynaud disease 10mg 3 times /day (maximum 20 mg 3 times /day). Hypertension and
angina prophylaxis 20mg twice daily after food, increased to 40mg twice daily if necessary.
8. Common S/E: Vasodilatation (flushing, headache, hypotension,dizziness, peripheral oedema),
paradoxical increase in ischaemic pain, GIT disturbance, gum hyperplasia and depression.
9. C/I: Cardiogenic shock, pregnancy, porphyria, who experience ischemic pain on its
administration.
10. Pregnancy category:c
11. Patient instructions: Visit dentist on routine basis because gum swelling may occur.
 There may be increase chest pain at short medication & with dose changes but this effect is
Transient.
 Use caution while performing tasks requiring mental alertness.
Sustained release capsules must be swallowed whole not chewed,divided or crushed.
12. Precautions: Hypotension, patients with poor cardiac reserve and breastfeeding.Reduce dose
in hepatic impairment. Adjustment of anti-diabetic dose may be required.
I. (C.V.S.) Anticoagulants(C.V.S.)
1. Generic name: Heparin salts
2. Brand name:Heparin sodium
3. Dosage form available : I.V
4. Strength available :1000iu, 5000 U, 12000 U
5. MOA:Potentiates the action of antithrobin III and inactivates throbin as well as activated
coagulation factor,IX,X,XI,XII and plasmin and prevents the conversion of fibrinogen to fibrin
6. Indication: Initiation of anti-coagulant therapy in deep venous Thrombosis (D V T),
disseminated intravascular coagulopathy and prophylaxis of postoperative thrombosis.
7. Dose and admn: Dose: 5000 U. I.V. followed by I.V. infusion of 1000 –2000 U/hour or 5000-
10,000 U I.V. every 4 hours By S.C prophylaxis of DVT 5000 u/2 hours before surgery, then every
8 – 12 hours until patient is ambulant, in pregnancy 10,000 U/12 hours. Treatment of DVT 10,000-
20,000 U/12 hours. Ampoules 12500 I.U., 20000 U, 5000 U, 12000 U, 5000 I.U. (1mg =130 U)
Indications: Initiation of anti-coagulant therapy in deep venous Thrombosis (D V T),
8. Common S/E: Haemorrhage, thrombocytopenia, hypersensitivity reactions and osteoporosis
after prolonged use.
9. C/I: Hypersensitivty to heparin, severe liver or kidney damage, peptic ulcer infective
endocarditis, hemorrhagic, blood disorders,severe trauma, administration by I.M route and cerebral
aneurysm and severe hypertension.
10. Pregnancy category:B
11. Patient instructions: Consult your physician or pharmacist when considering use of other
medications in particularly aspirin containing products or herbal products.
12. Precautions: When treatment is prolonged monitor activated partial thromoplastin time and
platelet count.
THANKS YOU GIVING
YOUR ATTENTION!!!

More Related Content

Similar to Pharmacy Practice Presentation1.pptx

5. Community Pharmacy.pptx
5. Community Pharmacy.pptx5. Community Pharmacy.pptx
5. Community Pharmacy.pptxVedika Narvekar
 
inroduction to clinical pharmcy.pdf
inroduction to clinical pharmcy.pdfinroduction to clinical pharmcy.pdf
inroduction to clinical pharmcy.pdfShailesh727104
 
communitypharmacy ppt.pdf
communitypharmacy ppt.pdfcommunitypharmacy ppt.pdf
communitypharmacy ppt.pdfShikhaSachde
 
Community pharmacy Internship
Community pharmacy InternshipCommunity pharmacy Internship
Community pharmacy Internshipvishalpanday2
 
Hospital pharmacy functions,organisation and responsibilities
Hospital pharmacy functions,organisation and responsibilitiesHospital pharmacy functions,organisation and responsibilities
Hospital pharmacy functions,organisation and responsibilitiesajitha27
 
Basic Dispensing lecture notes.docx
Basic Dispensing lecture notes.docxBasic Dispensing lecture notes.docx
Basic Dispensing lecture notes.docxkennyswift25
 
Code of Ethics for Pharmacists and Pharmacy Technicans Project
Code of Ethics for Pharmacists and Pharmacy Technicans Project Code of Ethics for Pharmacists and Pharmacy Technicans Project
Code of Ethics for Pharmacists and Pharmacy Technicans Project Areej Abu Hanieh
 
Community pharmacy training
Community pharmacy trainingCommunity pharmacy training
Community pharmacy trainingvishalpanday2
 
INTERNATIONAL PATIENT SAFETY GOALS.pptx
INTERNATIONAL PATIENT SAFETY GOALS.pptxINTERNATIONAL PATIENT SAFETY GOALS.pptx
INTERNATIONAL PATIENT SAFETY GOALS.pptxFarahAndleebMalik
 
Community pharmacy
Community pharmacyCommunity pharmacy
Community pharmacyVikas Soni
 
Community Pharmacy Ravinandan A P 7th Sem.pptx
Community Pharmacy  Ravinandan A P 7th Sem.pptxCommunity Pharmacy  Ravinandan A P 7th Sem.pptx
Community Pharmacy Ravinandan A P 7th Sem.pptxRavinandan A P
 
Introduction to Social Pharmacy.pptx
Introduction to Social Pharmacy.pptxIntroduction to Social Pharmacy.pptx
Introduction to Social Pharmacy.pptxishikachoudhary6
 
b. Clinical Pharmacy.pptx
b. Clinical Pharmacy.pptxb. Clinical Pharmacy.pptx
b. Clinical Pharmacy.pptxAnusha Are
 

Similar to Pharmacy Practice Presentation1.pptx (20)

5. Community Pharmacy.pptx
5. Community Pharmacy.pptx5. Community Pharmacy.pptx
5. Community Pharmacy.pptx
 
GOOD DISPENSING PRACTICES (GDP).pptx
GOOD DISPENSING PRACTICES (GDP).pptxGOOD DISPENSING PRACTICES (GDP).pptx
GOOD DISPENSING PRACTICES (GDP).pptx
 
Clinical supportive service department
Clinical supportive service departmentClinical supportive service department
Clinical supportive service department
 
Hospital Pharmacy Procedure
Hospital Pharmacy ProcedureHospital Pharmacy Procedure
Hospital Pharmacy Procedure
 
Clinical Pharmacy.pptx
Clinical Pharmacy.pptxClinical Pharmacy.pptx
Clinical Pharmacy.pptx
 
inroduction to clinical pharmcy.pdf
inroduction to clinical pharmcy.pdfinroduction to clinical pharmcy.pdf
inroduction to clinical pharmcy.pdf
 
communitypharmacy ppt.pdf
communitypharmacy ppt.pdfcommunitypharmacy ppt.pdf
communitypharmacy ppt.pdf
 
Pharmacy practice
Pharmacy practicePharmacy practice
Pharmacy practice
 
Community pharmacy Internship
Community pharmacy InternshipCommunity pharmacy Internship
Community pharmacy Internship
 
Hospital pharmacy functions,organisation and responsibilities
Hospital pharmacy functions,organisation and responsibilitiesHospital pharmacy functions,organisation and responsibilities
Hospital pharmacy functions,organisation and responsibilities
 
Basic Dispensing lecture notes.docx
Basic Dispensing lecture notes.docxBasic Dispensing lecture notes.docx
Basic Dispensing lecture notes.docx
 
Clinical Pharmacist 2016
Clinical Pharmacist 2016Clinical Pharmacist 2016
Clinical Pharmacist 2016
 
Clinical Pharmacy.pptx
Clinical Pharmacy.pptxClinical Pharmacy.pptx
Clinical Pharmacy.pptx
 
Code of Ethics for Pharmacists and Pharmacy Technicans Project
Code of Ethics for Pharmacists and Pharmacy Technicans Project Code of Ethics for Pharmacists and Pharmacy Technicans Project
Code of Ethics for Pharmacists and Pharmacy Technicans Project
 
Community pharmacy training
Community pharmacy trainingCommunity pharmacy training
Community pharmacy training
 
INTERNATIONAL PATIENT SAFETY GOALS.pptx
INTERNATIONAL PATIENT SAFETY GOALS.pptxINTERNATIONAL PATIENT SAFETY GOALS.pptx
INTERNATIONAL PATIENT SAFETY GOALS.pptx
 
Community pharmacy
Community pharmacyCommunity pharmacy
Community pharmacy
 
Community Pharmacy Ravinandan A P 7th Sem.pptx
Community Pharmacy  Ravinandan A P 7th Sem.pptxCommunity Pharmacy  Ravinandan A P 7th Sem.pptx
Community Pharmacy Ravinandan A P 7th Sem.pptx
 
Introduction to Social Pharmacy.pptx
Introduction to Social Pharmacy.pptxIntroduction to Social Pharmacy.pptx
Introduction to Social Pharmacy.pptx
 
b. Clinical Pharmacy.pptx
b. Clinical Pharmacy.pptxb. Clinical Pharmacy.pptx
b. Clinical Pharmacy.pptx
 

More from mZOn2

neonatalsepsis-160118135757.pdf
neonatalsepsis-160118135757.pdfneonatalsepsis-160118135757.pdf
neonatalsepsis-160118135757.pdfmZOn2
 
gyncase-110527205351-phpapp01.pdf
gyncase-110527205351-phpapp01.pdfgyncase-110527205351-phpapp01.pdf
gyncase-110527205351-phpapp01.pdfmZOn2
 
ectopic-pregnancy785-160118115205.pdf
ectopic-pregnancy785-160118115205.pdfectopic-pregnancy785-160118115205.pdf
ectopic-pregnancy785-160118115205.pdfmZOn2
 
seminaronhiv-180201064407.pdf
seminaronhiv-180201064407.pdfseminaronhiv-180201064407.pdf
seminaronhiv-180201064407.pdfmZOn2
 
strokepresentation-170712173032.ppt
strokepresentation-170712173032.pptstrokepresentation-170712173032.ppt
strokepresentation-170712173032.pptmZOn2
 
menopauseppt-140513004819-phpapp02.pdf
menopauseppt-140513004819-phpapp02.pdfmenopauseppt-140513004819-phpapp02.pdf
menopauseppt-140513004819-phpapp02.pdfmZOn2
 
12638718.ppt
12638718.ppt12638718.ppt
12638718.pptmZOn2
 
TB.PPT[1].pptx
TB.PPT[1].pptxTB.PPT[1].pptx
TB.PPT[1].pptxmZOn2
 

More from mZOn2 (8)

neonatalsepsis-160118135757.pdf
neonatalsepsis-160118135757.pdfneonatalsepsis-160118135757.pdf
neonatalsepsis-160118135757.pdf
 
gyncase-110527205351-phpapp01.pdf
gyncase-110527205351-phpapp01.pdfgyncase-110527205351-phpapp01.pdf
gyncase-110527205351-phpapp01.pdf
 
ectopic-pregnancy785-160118115205.pdf
ectopic-pregnancy785-160118115205.pdfectopic-pregnancy785-160118115205.pdf
ectopic-pregnancy785-160118115205.pdf
 
seminaronhiv-180201064407.pdf
seminaronhiv-180201064407.pdfseminaronhiv-180201064407.pdf
seminaronhiv-180201064407.pdf
 
strokepresentation-170712173032.ppt
strokepresentation-170712173032.pptstrokepresentation-170712173032.ppt
strokepresentation-170712173032.ppt
 
menopauseppt-140513004819-phpapp02.pdf
menopauseppt-140513004819-phpapp02.pdfmenopauseppt-140513004819-phpapp02.pdf
menopauseppt-140513004819-phpapp02.pdf
 
12638718.ppt
12638718.ppt12638718.ppt
12638718.ppt
 
TB.PPT[1].pptx
TB.PPT[1].pptxTB.PPT[1].pptx
TB.PPT[1].pptx
 

Recently uploaded

Presiding Officer Training module 2024 lok sabha elections
Presiding Officer Training module 2024 lok sabha electionsPresiding Officer Training module 2024 lok sabha elections
Presiding Officer Training module 2024 lok sabha electionsanshu789521
 
Software Engineering Methodologies (overview)
Software Engineering Methodologies (overview)Software Engineering Methodologies (overview)
Software Engineering Methodologies (overview)eniolaolutunde
 
ECONOMIC CONTEXT - LONG FORM TV DRAMA - PPT
ECONOMIC CONTEXT - LONG FORM TV DRAMA - PPTECONOMIC CONTEXT - LONG FORM TV DRAMA - PPT
ECONOMIC CONTEXT - LONG FORM TV DRAMA - PPTiammrhaywood
 
POINT- BIOCHEMISTRY SEM 2 ENZYMES UNIT 5.pptx
POINT- BIOCHEMISTRY SEM 2 ENZYMES UNIT 5.pptxPOINT- BIOCHEMISTRY SEM 2 ENZYMES UNIT 5.pptx
POINT- BIOCHEMISTRY SEM 2 ENZYMES UNIT 5.pptxSayali Powar
 
“Oh GOSH! Reflecting on Hackteria's Collaborative Practices in a Global Do-It...
“Oh GOSH! Reflecting on Hackteria's Collaborative Practices in a Global Do-It...“Oh GOSH! Reflecting on Hackteria's Collaborative Practices in a Global Do-It...
“Oh GOSH! Reflecting on Hackteria's Collaborative Practices in a Global Do-It...Marc Dusseiller Dusjagr
 
How to Make a Pirate ship Primary Education.pptx
How to Make a Pirate ship Primary Education.pptxHow to Make a Pirate ship Primary Education.pptx
How to Make a Pirate ship Primary Education.pptxmanuelaromero2013
 
Introduction to ArtificiaI Intelligence in Higher Education
Introduction to ArtificiaI Intelligence in Higher EducationIntroduction to ArtificiaI Intelligence in Higher Education
Introduction to ArtificiaI Intelligence in Higher Educationpboyjonauth
 
Alper Gobel In Media Res Media Component
Alper Gobel In Media Res Media ComponentAlper Gobel In Media Res Media Component
Alper Gobel In Media Res Media ComponentInMediaRes1
 
Enzyme, Pharmaceutical Aids, Miscellaneous Last Part of Chapter no 5th.pdf
Enzyme, Pharmaceutical Aids, Miscellaneous Last Part of Chapter no 5th.pdfEnzyme, Pharmaceutical Aids, Miscellaneous Last Part of Chapter no 5th.pdf
Enzyme, Pharmaceutical Aids, Miscellaneous Last Part of Chapter no 5th.pdfSumit Tiwari
 
Full Stack Web Development Course for Beginners
Full Stack Web Development Course  for BeginnersFull Stack Web Development Course  for Beginners
Full Stack Web Development Course for BeginnersSabitha Banu
 
Crayon Activity Handout For the Crayon A
Crayon Activity Handout For the Crayon ACrayon Activity Handout For the Crayon A
Crayon Activity Handout For the Crayon AUnboundStockton
 
internship ppt on smartinternz platform as salesforce developer
internship ppt on smartinternz platform as salesforce developerinternship ppt on smartinternz platform as salesforce developer
internship ppt on smartinternz platform as salesforce developerunnathinaik
 
Interactive Powerpoint_How to Master effective communication
Interactive Powerpoint_How to Master effective communicationInteractive Powerpoint_How to Master effective communication
Interactive Powerpoint_How to Master effective communicationnomboosow
 
Biting mechanism of poisonous snakes.pdf
Biting mechanism of poisonous snakes.pdfBiting mechanism of poisonous snakes.pdf
Biting mechanism of poisonous snakes.pdfadityarao40181
 
Final demo Grade 9 for demo Plan dessert.pptx
Final demo Grade 9 for demo Plan dessert.pptxFinal demo Grade 9 for demo Plan dessert.pptx
Final demo Grade 9 for demo Plan dessert.pptxAvyJaneVismanos
 
ECONOMIC CONTEXT - PAPER 1 Q3: NEWSPAPERS.pptx
ECONOMIC CONTEXT - PAPER 1 Q3: NEWSPAPERS.pptxECONOMIC CONTEXT - PAPER 1 Q3: NEWSPAPERS.pptx
ECONOMIC CONTEXT - PAPER 1 Q3: NEWSPAPERS.pptxiammrhaywood
 
18-04-UA_REPORT_MEDIALITERAСY_INDEX-DM_23-1-final-eng.pdf
18-04-UA_REPORT_MEDIALITERAСY_INDEX-DM_23-1-final-eng.pdf18-04-UA_REPORT_MEDIALITERAСY_INDEX-DM_23-1-final-eng.pdf
18-04-UA_REPORT_MEDIALITERAСY_INDEX-DM_23-1-final-eng.pdfssuser54595a
 

Recently uploaded (20)

Presiding Officer Training module 2024 lok sabha elections
Presiding Officer Training module 2024 lok sabha electionsPresiding Officer Training module 2024 lok sabha elections
Presiding Officer Training module 2024 lok sabha elections
 
TataKelola dan KamSiber Kecerdasan Buatan v022.pdf
TataKelola dan KamSiber Kecerdasan Buatan v022.pdfTataKelola dan KamSiber Kecerdasan Buatan v022.pdf
TataKelola dan KamSiber Kecerdasan Buatan v022.pdf
 
Software Engineering Methodologies (overview)
Software Engineering Methodologies (overview)Software Engineering Methodologies (overview)
Software Engineering Methodologies (overview)
 
ECONOMIC CONTEXT - LONG FORM TV DRAMA - PPT
ECONOMIC CONTEXT - LONG FORM TV DRAMA - PPTECONOMIC CONTEXT - LONG FORM TV DRAMA - PPT
ECONOMIC CONTEXT - LONG FORM TV DRAMA - PPT
 
POINT- BIOCHEMISTRY SEM 2 ENZYMES UNIT 5.pptx
POINT- BIOCHEMISTRY SEM 2 ENZYMES UNIT 5.pptxPOINT- BIOCHEMISTRY SEM 2 ENZYMES UNIT 5.pptx
POINT- BIOCHEMISTRY SEM 2 ENZYMES UNIT 5.pptx
 
“Oh GOSH! Reflecting on Hackteria's Collaborative Practices in a Global Do-It...
“Oh GOSH! Reflecting on Hackteria's Collaborative Practices in a Global Do-It...“Oh GOSH! Reflecting on Hackteria's Collaborative Practices in a Global Do-It...
“Oh GOSH! Reflecting on Hackteria's Collaborative Practices in a Global Do-It...
 
How to Make a Pirate ship Primary Education.pptx
How to Make a Pirate ship Primary Education.pptxHow to Make a Pirate ship Primary Education.pptx
How to Make a Pirate ship Primary Education.pptx
 
Introduction to ArtificiaI Intelligence in Higher Education
Introduction to ArtificiaI Intelligence in Higher EducationIntroduction to ArtificiaI Intelligence in Higher Education
Introduction to ArtificiaI Intelligence in Higher Education
 
Alper Gobel In Media Res Media Component
Alper Gobel In Media Res Media ComponentAlper Gobel In Media Res Media Component
Alper Gobel In Media Res Media Component
 
OS-operating systems- ch04 (Threads) ...
OS-operating systems- ch04 (Threads) ...OS-operating systems- ch04 (Threads) ...
OS-operating systems- ch04 (Threads) ...
 
Enzyme, Pharmaceutical Aids, Miscellaneous Last Part of Chapter no 5th.pdf
Enzyme, Pharmaceutical Aids, Miscellaneous Last Part of Chapter no 5th.pdfEnzyme, Pharmaceutical Aids, Miscellaneous Last Part of Chapter no 5th.pdf
Enzyme, Pharmaceutical Aids, Miscellaneous Last Part of Chapter no 5th.pdf
 
Full Stack Web Development Course for Beginners
Full Stack Web Development Course  for BeginnersFull Stack Web Development Course  for Beginners
Full Stack Web Development Course for Beginners
 
Crayon Activity Handout For the Crayon A
Crayon Activity Handout For the Crayon ACrayon Activity Handout For the Crayon A
Crayon Activity Handout For the Crayon A
 
internship ppt on smartinternz platform as salesforce developer
internship ppt on smartinternz platform as salesforce developerinternship ppt on smartinternz platform as salesforce developer
internship ppt on smartinternz platform as salesforce developer
 
Interactive Powerpoint_How to Master effective communication
Interactive Powerpoint_How to Master effective communicationInteractive Powerpoint_How to Master effective communication
Interactive Powerpoint_How to Master effective communication
 
Biting mechanism of poisonous snakes.pdf
Biting mechanism of poisonous snakes.pdfBiting mechanism of poisonous snakes.pdf
Biting mechanism of poisonous snakes.pdf
 
Model Call Girl in Tilak Nagar Delhi reach out to us at 🔝9953056974🔝
Model Call Girl in Tilak Nagar Delhi reach out to us at 🔝9953056974🔝Model Call Girl in Tilak Nagar Delhi reach out to us at 🔝9953056974🔝
Model Call Girl in Tilak Nagar Delhi reach out to us at 🔝9953056974🔝
 
Final demo Grade 9 for demo Plan dessert.pptx
Final demo Grade 9 for demo Plan dessert.pptxFinal demo Grade 9 for demo Plan dessert.pptx
Final demo Grade 9 for demo Plan dessert.pptx
 
ECONOMIC CONTEXT - PAPER 1 Q3: NEWSPAPERS.pptx
ECONOMIC CONTEXT - PAPER 1 Q3: NEWSPAPERS.pptxECONOMIC CONTEXT - PAPER 1 Q3: NEWSPAPERS.pptx
ECONOMIC CONTEXT - PAPER 1 Q3: NEWSPAPERS.pptx
 
18-04-UA_REPORT_MEDIALITERAСY_INDEX-DM_23-1-final-eng.pdf
18-04-UA_REPORT_MEDIALITERAСY_INDEX-DM_23-1-final-eng.pdf18-04-UA_REPORT_MEDIALITERAСY_INDEX-DM_23-1-final-eng.pdf
18-04-UA_REPORT_MEDIALITERAСY_INDEX-DM_23-1-final-eng.pdf
 

Pharmacy Practice Presentation1.pptx

  • 1. UNIVERSAL MEDICAL COLLEGE PRESENTESSION FOR PHARMACY PRACTICE ATTACHMENT BY SAMSON G/HIWOT ID.NO = PHDE/1604/12 FEB 2020
  • 2. Objectives of this attachment  To enable students identify those drugs which are commonly available in community pharmacy.  To enable students identify common emergency medicines available in community pharmacy.  To enable students develop capacity in provision of pharmaceutical care in community pharmacy.  To enable students identify those medical supplies which are available in community pharmacy.
  • 3. INTRODUCTION  Name of the organization is Simret Drug store  Simret Drug store Found in Debrebrehan Town North showa zone Infront of Debrebrehan Health center 04 kebele.  This organizations are contain two manpower(2 pharmacy professional)  One security  Average number of customers came in pharmacy per day = 55
  • 4.  Layout of the pharmacy  Human resource ◦ Pharmacy technicians, = 2 ◦ Other support staff ( guard). ◦ Pharmacist(s) and other staff on duty must wear a name tag or badge indicating his/her name and designation.
  • 5.  Appearance of pharmacy premises  Design and layout: ◦ Permit flow of work, effective communication and supervision and ensure effective cleaning ◦ Minimize the cross-contamination and anything else ◦ All parts of the premises was maintained in an orderly and tidy condition. ◦ The external appearance of the pharmacy depict a professional image. ◦ Entrances, dispensing counters and doorways are accessible to disabled persons.
  • 6.  Security in pharmacy premises  Careful consideration the overall security of the pharmacy. ◦ Access to a pharmacy when it is locked ◦ Control of access to medicine  Safety of pharmacy premises ◦ Working conditions ◦ Fire extinguisher ◦ Electrical equipment → safe and maintained regularly.  Condition of pharmacy premises  The walls, floors, windows, ceiling, and all other parts of the premises →cleaned and good ordered.  shelves and walls →finished in a smooth, washable and impermeable material.  Site of premises ◦ Fared from areas or premises that can cause contamination to the products and affect health in general (e.g. public toilets, waste dump site)
  • 7.  Construction of pharmacy premises  Preventing from: ◦ floods ◦ entry of insects, animals or birds  Easily cleaned and disinfected  Allows adequate lighting and air movement  Ceiling : ◦ Should minimizes effects of high temperatures ◦ Adequate height
  • 8.  Environment in pharmacy premises  Products stored according to recommended conditions  Levels of heat, light, noise, ventilation, etc., must exert no adverse effects on pharmaceutical stock as well as personnel.  Suitable and effective means of heating or cooling, lighting and ventilation.  Hygiene in pharmacy premises  Regular program for cleaning premises  Area for washing equipment and other utensils (hot and cold tap water).  Toilet facilities must be kept clean and in good order.  Hand-washing facilities
  • 9.  Premises Dispensary  The size of the dispensary:  allow a safe and efficient flow of work and  effective communication and supervision  arrangement of available space and  space available elsewhere for storage of stock.  Waiting area  Comfortable seating must be provided.  Appropriate health-related literature must be provided  This pharmacy fulfilled Ethiopian guideline like : 25m² minimum for dispensary and waiting area with shortest side not less than 4 m.
  • 10.  Suitability of dispensary  The dispensary, its fittings and equipment was adequate and suitable for the purpose of dispensing.  The temperature in the dispensing maintained below 25°C.  Counseling area  The area(s) ◦ Be easily accessible ◦ Ensured reasonable privacy to the patient at all times and eliminate background noise as far as possible. ◦ Have sufficient space →appropriate counseling and demonstration of the correct and safe use of medicines.
  • 11.  Storage areas in pharmacy premises ◦ independent and secured ◦ Large enough → orderly arrangement and proper stock rotation ◦ Sufficient shelving  Fulfilled Ethiopian guideline like : 16 m² minimum for storage with shortest side not less than 3 m.  Other issues  Waste disposal → SOPs ◦ Suitable and adequate means in written form  Dispensing equipment and materials ◦ Adequate, suitable dispensing equipment. (not all) ◦ Maintained clean,  Availability of Refrigerator
  • 12. Services rendered in community pharmacy  The major work of community pharmacists involves supplying medicines to the public: 1. Dispensing prescriptions 2. Patient information and advice 3. Compounding 4. Record keeping 5. Public health Services 6. Medication therapy management (MTM) and standards
  • 13. 1. Dispensing prescriptions 1. Dispensing prescriptions  The supply of medicines according to:  Good dispensing practices,  Good compounding practices  Maintaining records and  SOPs followed
  • 14.  Good dispensing practices  The dispensing process is divided into three phases, namely:  Phase 1: Interpretation and evaluation of the prescription.  Phase 2: Labeling and preparation of the prescribed medicine.  Phase 3: Hand to the patient and counseling.  Phase 1: Interpretation and evaluation of the prescription  Receipt of the prescription and confirmation of the integrity of the communication. ◦ identifying the patient, the prescriber, ◦ legality/authenticity of the prescription, ◦ medication history
  • 15.  Phase 2: Labeling and preparation of the prescribed medicine  Labeling of item(s)  Selecting or preparing the medicine ◦ patient-ready packs/pre-packed medicines ◦ extemporaneous preparations ◦ pharmaceutical containers  Checking  Record keeping regarding the supply of medicine
  • 16.  Phase 3: Hand to the patient and Counseling  Supply to the patient  Counseling to be done by a pharmacist  Patient information leaflet  Monitoring patient outcomes  assess the patient for signs of compliance, effectiveness and safety of the therapy  identify areas for interventions, intervene, revise the patient record and record the action taken  Read: Ethiopian Good Dispensing Manual
  • 17. 2. Patient information and advice  Patient information and advice is of vital importance in the correct use of medicines  It must respect patient autonomy, improve health and enhance the outcome of medical treatment by: ◦ empowering consumers to make informed decisions about their treatments and take responsibility for their own health care; ◦ improving communication between patients and health care providers; and ◦ aiding and encouraging effective use of medicines.  Supplementary written information must be used (as appropriate).  The pharmacist must assess each patient's ability to understand the information imparted.  Confidentiality of the patient must be respected.  The provision of advice must take place in a suitable environment.
  • 18.  Steps for counseling a patient on a new prescription o Introduce yourself and identify the patient. o Ask patient to talk with you about the medication. o Assess the patient's understanding of his/her disease and expected outcomes of therapy. o Assess patient’s knowledge about the newly prescribed drug and the reason it was prescribed. o Assess patient’s knowledge on how to take the medication as well as its potential adverse effects.
  • 19. 3. GOOD COMPOUNDING PRACTICE (GCP)  Definition  Compounding is the preparation of a customized prescription medication to meet the individual patient needs in response to a licensed practitioner's prescription.  Why Compound?  Problem Solving…  Unavailable Strength/Dosage  Unavailable Medications (limited use, short shelf life, etc.)  Sensitivity to Dyes, Fillers, Preservatives  Basic components of GCP  Personnel  Facilities  Equipment  Ingredients  The compounding process  Packaging and labeling  Stability and beyond-use date  Records and reports
  • 20. 4. Record keeping  Must be both accurate and up-to-date. ◦ Compounding record ◦ Prescription Registration ◦ Patient medication records ◦ Stock records ◦ Health-screening related
  • 21. 5. public health service  Public health is part of the community pharmacist’s roles: ◦ Disease prevention ◦ Health promotion  Promoting healthy lifestyles consists of two separate areas: ◦ prescription-linked intervention ◦ involvement in public health campaigns.  Prescription-linked intervention involves offering opportunistic advice on public health topics to patients that present a prescription.  Promotion of healthy lifestyles will include offering advice in the following areas: ◦ STDs and HIV/AIDS ◦ Infectious diseases such as malaria, URTIs and diarrheal diseases ◦ FP and child care ◦ Antimicrobial resistance ◦ CVDs, Cancer, Diabetes  Health issues: stopping smoking, alcohol intake, nutrition advice and increased physical activity, etc.
  • 22.  Other professional services  Retailing  Remuneration/methods of payment: ◦ Markups on individual items and income derived solely from the sale of medicines, ◦ Fixed dispensing fees  Managerial skills  Financial strategy and planning  Marketing  Problem solving  Emergency hormonal contraceptives (‘morning-after-pill’).  Emergency contraception (EC) refers to contraceptive methods that may be used in the first few days after unprotected sexual intercourse, to prevent unwanted pregnancy.  It potentially reduces unintended pregnancy and (unsafe) abortion rates.
  • 23.  Health screening: ◦ Body weight and height; ◦ Blood pressure; ◦ Blood glucose; ◦ Pregnancy; ◦ Cholesterol; ◦ Peak flow test; ◦ HIV  Requirements: facilities and training  Appropriate public health education and counseling
  • 24.  First aid provision  Emergency treatment of wounds; bone fractures; burns; bleeding; foreign objects in nose, ear, eye and respiratory system; severe diarrhea; high fever; poisoning and snake bite; etc.  Adverse drug reaction reporting o Report suspected adverse drug reactions (ADRs) to the regulatory body (e.g. Food, Medicines and Healthcare Administration and Control Authority, FMHACA) o For new drugs that have received market authorization in the last 2 years) for which any suspected ADRs should be reported o All other drugs, for which only serious suspected ADRs should be reported.  Nutrition advice (diabetes, hypertension, pregnancy, etc.)
  • 25.  Site for training of pharmacy interns  Drug information services ◦ General public ◦ Healthcare providers  Immunization services ◦ travel, ◦ childhood, ◦ tetanus, etc.  Smoking cessation clinics  Pharmacies are recognized as being well placed to offer a smoking-cessation service as they are readily accessed by the public and have a resident healthcare professional.  Pharmacists are involved routinely in brief interventions as part of the essential service promoting healthy lifestyles.  Initial and follow up consultations  Nicotine replacement therapy (NRT)  NRT delivers nicotine in a clean form and helps smokers to overcome withdrawal symptoms such as irritability and craving while avoiding the many harmful chemicals in tobacco and the carbon monoxide that cause serious damage.  There are many different forms of NRT available including patches, gum, sublingual tablets, lozenges, inhalators and nasal spray.
  • 26. 6. Medication therapy management (MTM)  Requirements for MTM Programs are “designed” to “optimize therapeutic outcomes through improved medication use” and “reduce the risk of adverse events, including adverse drug reactions.”  Objectives are to increase patient adherence, prevent drug complications, and enhance patient understanding of their medication therapy.  A MTM program established for targeted beneficiaries such as those who o have multiple chronic disease states o are taking multiple drugs,  Core elements for MTM services  Medication therapy review,  Personal medication record,  Medication-related action plan,  Intervention and/or referral, and  Documentation and follow-up
  • 27. OBSERVA TION A ND DISCUSSION  Strength  supplying medicines to the public: 1. Dispensing prescriptions 2. Patient information and advice 3. Record keeping 4. Medication therapy management (MTM)and standards
  • 28. ◦ Minimize the cross-contamination and anything else ◦ All parts of the premises was maintained in an orderly and tidy condition. ◦ The external appearance of the pharmacy depict a professional image.  Entrances, dispensing counters and doorways are accessible to disabled persons.  Safety of pharmacy premises ◦ Working conditions ◦ Fire extinguisher ◦ Electrical equipment → safe and maintained regularly.
  • 29.  The walls, floors, windows, ceiling, and all other parts of the premises →cleaned and good ordered.  shelves and walls →finished in a smooth, washable and impermeable material.  Construction of pharmacy premises  Preventing from: ◦ floods ◦ entry of insects, animals or birds  Easily cleaned and disinfected  Allows adequate lighting and air movement  Ceiling : ◦ Should minimizes effects of high temperatures ◦ Adequate height
  • 30.  Environment in pharmacy premises  Products stored according to recommended conditions  Levels of heat, light, noise, ventilation, etc., must exert no adverse effects on pharmaceutical stock as well as personnel.  Suitable and effective means of heating or cooling, lighting and ventilation.  Hygiene in pharmacy premises  Regular program for cleaning premises  Area for washing equipment and other utensils (hot and cold tap water).  Toilet facilities must be kept clean and in good order.  Hand-washing facilities
  • 31.  Waiting area  Comfortable seating must be provided.  Suitability of dispensary  The dispensary, its fittings and equipment was adequate and suitable for the purpose of dispensing.  The temperature in the dispensing maintained below 25°C.  Counseling area  The area(s) ◦ Be easily accessible ◦ Ensured reasonable privacy to the patient at all times and eliminate background noise as far as possible.  Have sufficient space
  • 32.  Storage areas in pharmacy premises ◦ independent and secured ◦ Large enough → orderly arrangement and proper stock rotation ◦ Sufficient shelving  Waste disposal → SOPs ◦ Suitable and adequate means in written form  Have Good stock clasification methode  Dispensing equipment and materials ◦ Adequate, suitable dispensing equipment. (not all) ◦ Maintained clean,
  • 33. Weakness  Prescribed Prescription drugs with out physician  No ADR registration form  No Report format (IFRR/RRF)  NO BIN CARd  There is no Compounding room  There is no  secretarial  managerial activities office with appropriate furniture and equipments  stock recording and other relevant documents are no applicable  No participated in Health education  Common ones include: ◦ Tablets and capsules counting equipments/apparatuses have not .
  • 34.  Have not Current editions available like : ◦ Martindale; ◦ Drug interactions reference source; ◦ a comprehensive textbook on pharmacology/pharmacotherapy; ◦ Standard Treatment Guidelines and Essential Drug List for the appropriate level of care. ◦ A pediatric dosing reference guide (where applicable); ◦ A medical dictionary;  Dispensing equipment and materials are o Not Adequate and suitable dispensing equipment.  Have no Staff room like:- ◦ Cloak room ◦ Tea room  There is no cashier, accountant, cleaner in the layout of the pharmacy
  • 35. Contribution/lesson learned during staying  From this lesson I learned about Services given to the Community Pharmacy like: 1. Dispensing prescriptions 2. Patient information and advice 3. Record keeping 4. Medication therapy management (MTM) and standards
  • 36.  I contributed that different areas specialy occurring of the weakness  I make a significant contribution to public health through their day-to-day activities. These include :- o provision of information and advice, o facilitating self-care, o care and support of drug users, o visits to the homes of housebound people o advice on smoking cessation and o emergency hormonal contraception. o I dispensed prescription and non prescription drugs with stepwise o I given adequated patient information and advices o I prepared adequated record keeping materials o I given health education about infection prevention for the public o I recommended to fullfilled the occurrence of weakness like,compounding room,separate tea room,current editions available,dispensing equipement,medicine counter and record keeping log books.
  • 37. o Finally ,I contributed and recommended that all pharmacy professionals responsible for appropriate use of medication, and to achieve optimum therapeutic outcomes like:-  Cure of a disease  Elimination or reduction of a patient’s symptoms  Arresting or slowing of a disease process  Preventing a disease
  • 38. .During attachment peroid I attracted by availability of different drugs  patient privacy Patient satisfaction
  • 39. SUMMA RY A ND R ECOMMENDA TIONS  Based on occurance of the weakness the following recommendations were made for future actions:  The pharmacy professionals should work hard to fulfilled atleast minimum standards.  They should fulfilled compounding room in the next months  They should fulfilled secretarial ,managerial activities office with appropriate furniture and equipments  They should applicable stock recording and other relevant documents  Tablets and capsules counting equipments should be applicable
  • 40.  Current editions should be available like :- ◦ Martindale; ◦ Drug interactions reference source; ◦ a comprehensive textbook on pharmacology/pharmacotherapy; ◦ Standard Treatment Guidelines and Essential Drug List for the appropriate level of care. ◦ A pediatric dosing reference guide (where applicable); ◦ A medical dictionary;  They should be fullfilled Adequate and suitable dispensing equipment.  They should be fulfilled cashier, accountant, cleaner in the layout of the pharmacy  They should be avail Staff room like:- ◦ Cloak room ◦ Tea room
  • 41. The community pharmacy professionals should be  avoid non phycians prescreptions  Avail bin card,  Avail ADR registration form  Avail Report format (IFRR/RRF) 6/13/2023 41
  • 42. 3. References  (http://fmhaca.gov.et/Documents/Good Dispensing manual new 2.pdf)  Hassan, W. E. Jr. Hospital Pharmacy, 5th ed. Lea and Febiger, Philadelphia, 1986.  Remington’s Pharmaceutical Science, 21st ed., Lippincott Williams & Wilkins, Pennsylvania, 2006.  Peterson A. M. Managing Pharmacy Practice: Principles, Strategies, and Systems, CRC, Boca Raton, 2004.  FMHACA documents listed in the text.
  • 43. 5 .U N SELIN G TIP M ON OGR A PH PR EPA R ATION I. Gastro-intestinal Tract Drugs(G.I.T.) 1. Generic name -Metoclopramide: 2. Brand name :RegurgeR 3. Dosage form available : tablets and solution) and as a parenteral preparation for intravenous or intramuscular use. 4. Strength available :5mg,10mg 5. MOA:Block dopamine receptors when given in higher doses)also block serotonine receptors in CTZ of the CNS;enhances the response to Ach ofb tissue in upper RT causing enhanced motility and accelerated gastric emptying with out stimulating gastric,biliary or pancreatic secretions,increase LEST 6. Indication: In non-ulcer dyspepsia, for speeding transit time of barium during intestinal induced nausea and vomiting, in oesophageal reflux. 7. Dose and admn : Oral,I.M. or I.V., 10 mg (5 mg in Patients15-19 years) 3 times/day.Child up To 1year1mg twice / day;1-3 years1 mg 2-3 times/day; 5-9 years 2.5 mg 3 times /day; 9-14 years 5 mg 3 times / day. Before radiological examination,a single I.M dose of 10-20 mg (10 mg in young adults); childunder 3 years 1 mg, 5-9 years 2.5 mg, 9-14 years 5 mg by continuous I.V. infusion, before starting chemotherapy, 2-4/kg mg over 15-30 minutes, hen 3-5 mg/kg over 8-12 hours (maximum 10 mg/kg/day).
  • 44. 8.Common S/E: May induce extrapyramidal manifestations (facial and skeletal muscle spasm and oculogyric crisis) in young patients. 9.C/I: GIT hemorrhage, obstruction, perforation or immediately after surgery 10.Pregnancy category:C 11.Patient instructions: Patient instructions: Take each dose 30 minutes before meals and at bedtime. Use caution when performing other tasks requiring mental alertness. Report any involuntary movements especially in children and elderly. 12.Precautions: Renal and hepatic impairment; in elderly and under 20 years,pregnancy and lactation, patients with hypertension, parkinsonism,history of depression and after gut anastomosis in patients with diabetic gastroparesis,insulin dosage or timing might require adjustment.
  • 45. 1. Generic name - Aluminum Hydroxide Combinations 2. Brand name : ALUSIL,NORMACID MPS GELR 3. Dosage form available :Chewable tablets and Suspensions 4. Strength available :370mg,475mg suspension 5. MOA:by neutralizing Acid-capacity 6. Indication: For use in dyspepsia and in hyperphosphataemia. 7. Dose and admn: Suspension, 5-10 ml (tablets,1-2 tablets chewed)4 times /day between and bedtime.Child 6-12 year, up to 5 ml times /day. 8. Common S/E: Constipation, intestinal obstruction (large doses),hypercalciuria and risk of osteomalacia. 9. C/I: Hypophosphataemia, porphyria, undiagnosed gastrointestinal or rectal bleeding. 10. Pregnancy category:C excretion in breast milk unknown 11. Patient instructions:  Do not take for longer than 2 weeks.  Taking too much can cause stomach to secrete excess stomach acid.  Reduce acidity for about 30 minutes when taken on an empty stomach and for about 3 hours when taken 1 hour after meals. 12. Precautions: impaired renal function and renal dialysis, constipation,dehydration, fluid restriction
  • 46. I. Antispasmodics 1. Generic name : Atropine sulphate 2. Brand name :AtrezaR ,AtropineR 3. Dosage form available : I.V injection 4. Strength available :1mg/ml 5. MOA: Atropine antagonizes the effect of acetylcholine by competing for the muscarinic receptors peripherally and in the CNS; therefore the effects of atropine are opposite to the acetylcholine effects. 6. Indication: Adjust to the treatment of gastric and duodenal ulcers to facilitate radiological examination of the gut,treatment of irritable bowel syndrome,with opiate analgesics in biliary and ureteric colics, in parkinsonism, in the treatment of some arrhythmias (sinus bradycardia and heart block), in the treatment of irreversible anti-cholinesterase poisoning, mushroom poisoning as a pre-medicate in anesthesia with neostigmine to control its side effects in reversal of competitive neuro-muscular blockers and in ophthalmology ( refraction , iridocyclitis and convergent squint )
  • 47. 7. Dose and admn: Pre-medicated, I.V injection, 300-600 micrograms immediately before induction and in incremental doses of 100 micrograms for the treatment of bradycardia.With neostigmine, 0.6-1.2 mg 8. Common S/E: - lower doses produce sedation - higher doses produce excitation, agitation and hallucination - Dry mouth, constipation, mydriasis and cycloplegia,increased intra-ocular pressure, flushing, rashes, dry skin, palpitations and arrhythmia and difficulty in micturition 9. C/I: Glaucoma, prostatic enlargement, pyloric stenosis,ulcerative colitis, hepatic and renal disease, tachycardia, myocardial ischemia, myasthenia gravis, unstable cardiovascular status, in acute hemorrhage. 10. Pregnancy category:C 11. Patient instructions:  Adequate oral fiber intake  Not to drive, dilated pupils (mydriasis). 12. Precautions: Extremes of age, infants below 3 month, fever, thyrotoxicosis,cardiac insufficiency, hypertension, Down syndrome
  • 48. I. Selective Angiotensin II inhibitor(C.V.S.) 1. Generic name: Nifedipine 2. Brand name :Nife – SSP20,Afeditab CR 3. Dosage form available :20mg,40mg tablets 4. Strength available :20mg,40mg tablets 5. MOA: inhibition of calcium influx in to arterial smooth muscle cells, 6. Indication: Angina pectoris (classic and vasospastic), hypertension and Raynaud disease. 7. Dose and admn: Angina, initially 10mg 3 times /day, increase to 20 mg 3 times / day if necessary. In elderly initially 5mg 3 times /day (for immediate effect bite capsule and retain liquid in mouth). Raynaud disease 10mg 3 times /day (maximum 20 mg 3 times /day). Hypertension and angina prophylaxis 20mg twice daily after food, increased to 40mg twice daily if necessary. 8. Common S/E: Vasodilatation (flushing, headache, hypotension,dizziness, peripheral oedema), paradoxical increase in ischaemic pain, GIT disturbance, gum hyperplasia and depression. 9. C/I: Cardiogenic shock, pregnancy, porphyria, who experience ischemic pain on its administration. 10. Pregnancy category:c 11. Patient instructions: Visit dentist on routine basis because gum swelling may occur.  There may be increase chest pain at short medication & with dose changes but this effect is Transient.  Use caution while performing tasks requiring mental alertness. Sustained release capsules must be swallowed whole not chewed,divided or crushed. 12. Precautions: Hypotension, patients with poor cardiac reserve and breastfeeding.Reduce dose in hepatic impairment. Adjustment of anti-diabetic dose may be required.
  • 49. I. (C.V.S.) Anticoagulants(C.V.S.) 1. Generic name: Heparin salts 2. Brand name:Heparin sodium 3. Dosage form available : I.V 4. Strength available :1000iu, 5000 U, 12000 U 5. MOA:Potentiates the action of antithrobin III and inactivates throbin as well as activated coagulation factor,IX,X,XI,XII and plasmin and prevents the conversion of fibrinogen to fibrin 6. Indication: Initiation of anti-coagulant therapy in deep venous Thrombosis (D V T), disseminated intravascular coagulopathy and prophylaxis of postoperative thrombosis. 7. Dose and admn: Dose: 5000 U. I.V. followed by I.V. infusion of 1000 –2000 U/hour or 5000- 10,000 U I.V. every 4 hours By S.C prophylaxis of DVT 5000 u/2 hours before surgery, then every 8 – 12 hours until patient is ambulant, in pregnancy 10,000 U/12 hours. Treatment of DVT 10,000- 20,000 U/12 hours. Ampoules 12500 I.U., 20000 U, 5000 U, 12000 U, 5000 I.U. (1mg =130 U) Indications: Initiation of anti-coagulant therapy in deep venous Thrombosis (D V T), 8. Common S/E: Haemorrhage, thrombocytopenia, hypersensitivity reactions and osteoporosis after prolonged use. 9. C/I: Hypersensitivty to heparin, severe liver or kidney damage, peptic ulcer infective endocarditis, hemorrhagic, blood disorders,severe trauma, administration by I.M route and cerebral aneurysm and severe hypertension. 10. Pregnancy category:B 11. Patient instructions: Consult your physician or pharmacist when considering use of other medications in particularly aspirin containing products or herbal products. 12. Precautions: When treatment is prolonged monitor activated partial thromoplastin time and platelet count.
  • 50. THANKS YOU GIVING YOUR ATTENTION!!!